Casabronstein méier resultado

Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 13 abril 2025
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Trends in survival during the pandemic in patients with critical
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
The efficiency and safety of high-dose vitamin C in patients with
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical Characteristics and Outcomes of Patients With Severe
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Estimates of the severity of coronavirus disease 2019: a model
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Evaluation of infliximab/tocilizumab versus tocilizumab among
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
COVID-19 and COPD: a narrative review of the basic science and
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Prevalence, characteristics, and longer-term outcomes of patients
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Full article: Impact of prior vaccination on clinical outcomes of
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Survival in adult inpatients with COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Characteristics and outcomes of sepsis patients with and without
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Remdesivir for the Treatment of Covid-19 — Final Report
Recomendado para você
você pode gostar

© 2014-2025 likytut.eu. All rights reserved.